Clinical Trials Logo

Filter by:
NCT ID: NCT06018194 Recruiting - Clinical trials for Coronary Artery Disease

ELUCIDATE FFRct Study

Start date: September 1, 2023
Phase:
Study type: Observational

The goal of this study is to evaluate the diagnostic accuracy of a novel plaque-based coronary CT angiography (CCTA) fractional flow reserve (FFRct) software device for the estimation of invasive fractional flow reserve (FFR). Researchers will compare the Elucid plaque-based FFRct analysis to invasively measured FFR in patients who have previously undergone CCTA and invasively assessed FFR.

NCT ID: NCT06018168 Completed - Acne Clinical Trials

An RCT Evaluating the Efficacy of a Skincare Routine and Acne Supplement on Improving Acne and Other Symptoms of PMS

Start date: June 30, 2023
Phase: N/A
Study type: Interventional

This study aims to evaluate the efficacy of the MINDBODYSKIN Hormonal Acne Supplement and a prescribed skincare routine of 6 products on facial acne and on symptoms of PMS, compared to a skincare routine of 6 products alone. This study will last for 24 weeks. The study will be conducted as a randomized, controlled trial in which participants will be split into two groups. Both will use the skincare routine, but one group will also take the MINDBODYSKIN supplement in combination with the skincare routine.

NCT ID: NCT06018129 Recruiting - Clinical trials for Non-Hodgkin Lymphoma

A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma

Start date: September 21, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this trial is to evaluate the safety, tolerability, immunogenicity, pharmacokinetics (PK), pharmacodynamics (PD), and anti-tumor activity of GEN3017 as a monotherapy in participants with relapsed or refractory (R/R) CD30-expressing lymphomas. GEN3017 will be administered via subcutaneous injections. All participants will receive active drug; no one will be given placebo.

NCT ID: NCT06018064 Recruiting - Infant Development Clinical Trials

Investigating Fit and Satisfaction of the Prone Positioner

Start date: September 21, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about the use of the Prone Positioner in pediatric patients with tracheostomies (trachs). The main question[s] it aims to answer are: - What is the fit and satisfaction of the device? - Does the device fulfill the goal of allowing infants with trachs participate in tummy time - What aesthetic feedback will the study team receive on the prone positioner from families, therapists, and nursing staff. Participants will be placed in the Prone Positioner, they will be monitored for their comfort/satisfaction with use, and how well they are able to be receive ventilation while in the device. Parents of these infants, as well as healthcare providers, will be surveyed on thoughts/suggestions for the Prone Positioner.

NCT ID: NCT06018025 Recruiting - Clinical trials for New Persistent Daily Headache

NDPH Biomarker Study in Children and Adolescents

Start date: March 1, 2024
Phase:
Study type: Observational [Patient Registry]

This study will recruit pediatric patients with NDPH (New Daily Persistent Headache), characterize their headache in a standard manner, and treat the NDPH with standard medications used for treatment of headaches in this population. Response to treatment with CGRP blocking Ab medications will be evaluated. Biomarkers related to headache disorders will be measured before and after treatment.

NCT ID: NCT06017999 Recruiting - Acute Pain Clinical Trials

XG005 for Pain Control in Subjects Undergoing Bunionectomy

Start date: August 8, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

This study will evaluate the safety, efficacy, and PK of low dose (750 mg) and high-dose (1250 mg) XG005 oral tablets compared with placebo in subjects undergoing bunionectomy. Subjects will be confined in the clinic from check-in through 72 hours post-surgery to monitor subject safety.

NCT ID: NCT06017986 Recruiting - Metabolic Diseases Clinical Trials

The Effect of Processing on Food Reward

PFR
Start date: July 1, 2023
Phase: N/A
Study type: Interventional

The minimally processed diets of our ancestors have been rapidly replaced by UPFs driving poor diet to become the leading risk factor for preventable death globally. Hence, it is essential to understand what properties of UPF are driving their overconsumption to reduce diet-related mortality. To address this gap in knowledge this proposal will test: - If UPFs have a greater post meal metabolic response when compared to MPFs an essential signal for food reward - Through the use of an auction task paradigm if UPFs overvalued and if this value is differentially encoded in the brain This study is a fully cross-over design in that each participant receives all conditions and therefore serves as their own control. All orders of foods will be counterbalanced. Although participants cannot be blinded to the conditions as they must be aware of the foods they are eating, they will not be made aware that the key manipulation is food processing. On different days participants will come to the lab and consume a meal containing either minimally or ultra-processed foods as determined by the widely used NOVA (not an acronym) scale. These conditions will be consumed in a whole room metabolic chamber allowing for simultaneous measurement of multiple metabolic responses (glucose, insulin, and metabolic rate). These measures will be collected for 45 min before consumption of the meal (baseline) and for 3 hours after consumption (post-prandial). All participants will also undergo a Becker-Degroot-Marschak auction paradigm that consists of foods that are either minimally or Ultra-processed in the MRI scanner. Food value will be measure in participants' willingness to pay for each food and Neural responses will be measured during presentation of the food cues.

NCT ID: NCT06017752 Completed - Bullying Clinical Trials

Middle School Teacher Module for a Brief Bullying Intervention Program

Start date: January 21, 2022
Phase: N/A
Study type: Interventional

This study evaluates the feasibility and short-term outcomes of a teacher training designed as a companion module to a bullying bystander intervention (STAC) for middle school students in rural communities. The aim of this project is to provide a brief, low-cost intervention that can be easily disseminated as part of a school-based bullying prevention program to address this important public health problem.

NCT ID: NCT06017687 Recruiting - General Population Clinical Trials

Data Collection and Evaluation of OptiBP Under Investigational Use

Start date: September 28, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to collect data to develop and evaluate the use of state-of-the-art machine learning approaches within a mobile phone application for the estimation of blood pressure.

NCT ID: NCT06017622 Recruiting - Clinical trials for Acute Cannabinoid Intoxication

Observational Study of THC Concentrations in Acute Cannabinoid Intoxication

Start date: June 1, 2023
Phase:
Study type: Observational

This observational study is being conducted to determine plasma concentrations of tetrahydrocannabinol (THC) and its metabolites, 11-OH-THC and THC-COOH, in plasma of subjects who visit the emergency department due to acute cannabinoid intoxication.